Thoughts

Signals – quick single insights or data points
Notes – medium-length reflections
Longer in-depth essays

Joel Selanikio Joel Selanikio

Which AI is Best for Doctors? We Still Don't Know

Two head-to-head studies of medical AI came out weeks apart and reached opposite conclusions — one says general-purpose AI wins, the other says OpenEvidence does. Neither answers the question every doctor is actually asking: which one should I use in my practice?

Read More
Joel Selanikio Joel Selanikio

One Step Closer: AI Prescribing Drugs

The FDA just cleared UpDoc, software that adjusts medication doses between doctor visits — close to what Doctronic has been running in Utah. In both, AI does what only a licensed prescriber used to, and both stay inside the system for now. Sustaining innovation for the system, potentially disruptive for the doctor.

Read More
Joel Selanikio Joel Selanikio

AI Is Already Practicing Medicine

A surgeon posted on on LinkedIn that Silicon Valley, incorrectly, believes AI will be practicing medicine "momentarily." But AI has been diagnosing diabetic retinopathy with no physician since 2018, and this year another began renewing prescriptions in Utah. Both AI vendors carry malpractice insurance — because both AI systems are practicing medicine.

Read More
Joel Selanikio Joel Selanikio

Signals: Utah's AI Prescriber Was More Cautious Than the Doctors Auditing It

Five months into Utah's Doctronic pilot — the first US program authorizing AI to recommend prescription renewals — the state just released outcome data. The AI's renewal recommendations are statistically indistinguishable from a second physician's. And when the AI defers to a human, it defers more often than a human would.

Read More
Joel Selanikio Joel Selanikio

Your Doctor’s Favorite AI Has Never Been Tested

40% of U.S. physicians use OpenEvidence. DoxGPT had 300,000 clinician users last quarter. UpToDate just launched Expert AI. Not one of these tools appears to have been independently tested for accuracy or safety. A profession built on evidence-based medicine is adopting AI with no evidence.

Read More
Joel Selanikio Joel Selanikio

When Enterprise Health AI Makes a Mistake, Who’s Liable?

Medicine has a well-established model for distributing liability across physicians and tools: whoever caused the failure bears the liability. AI vendors have quietly opted out of it — and the contracts they're asking health systems to sign reflect that.

Read More
Joel Selanikio Joel Selanikio

OpenAI vs. Anthropic: Two Bets on Enterprise Healthcare AI

OpenAI and Anthropic both launched enterprise healthcare AI offerings last month. OpenAI's is more complete — a ready-to-use product for clinicians plus an API for developers. Anthropic's is developer-focused, with connectors to healthcare databases like CMS and ICD-10. Both will eventually offer the full stack. The question is what you need now.

Read More
Joel Selanikio Joel Selanikio

When Consumer Health AI Makes a Mistake, Who's Liable?

In the first week of January 2026, Utah, and OpenAI each drew a different line around health AI—and liability. Utah’s Doctronic pilot treats AI like a clinician, with malpractice coverage and preserved remedies. OpenAI adds medical-record syncing under unchanged disclaimers and a $100 cap.

Read More
Joel Selanikio Joel Selanikio

From Exam Room to Living Room: The New Health System, Part 1

For the last 50 years, the engine of technology innovation has been a consumer engine. Consumers have steadily accumulated new health capabilities—including diagnosis, treatment, and monitoring—much faster than healthcare organizations. This has caused a decades-old, large-scale migration of health-related activity from the healthcare system to the consumer tech system. But in my experience speaking with hundreds of healthcare CEOs and board members, these migrations remain largely invisible to healthcare leadership.

Read More
Joel Selanikio Joel Selanikio

Digital Coaches, Part III: FDA + Utah Accelerating the Consumer Health Shift

The FDA just updated its General Wellness guidance, allowing consumer devices to measure clinical parameters for coaching—no clearance required. The same week, Utah let AI renew prescriptions with no doctor. Both are doing the same thing: moving healthcare tasks out of traditional systems and into consumer channels.

Read More
Joel Selanikio Joel Selanikio

The Rise of Digital Health Coaches

AI health coaches aren’t just for athletes anymore. They’re starting to handle the day-to-day interpretation, advice, and treatment adjustments that once required doctors. From glucose monitoring to hypertension management, technologies like Dexcom, Teladoc, and Omada are quietly taking over the work of routine clinical decision-making. This new generation of digital health coaches marks the next step in a long trend — technology shrinking healthcare by making us need it less.

Read More
Joel Selanikio Joel Selanikio

AI in Coverage Decisions: We Need Guardrails, Not Prohibition

Lawmakers are moving to ban AI-only insurance denials, requiring human sign-off for every case. It sounds compassionate, but it locks us into the same slow, opaque, costly system. The smarter move is AI with guardrails — transparency, audits, and contestable rationales — for faster, clearer, more accountable decisions.

Read More